The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 192.50
Bid: 190.00
Ask: 195.00
Change: -3.50 (-1.79%)
Spread: 5.00 (2.632%)
Open: 193.00
High: 198.00
Low: 192.50
Prev. Close: 196.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

Wed, 23rd Feb 2022 20:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Begbies Traynor Group PLC - Manchester-based corporate rescue and recovery company - Says its third quarter which ended January 31 had performed broadly in line with the first half. As a result, Begbies Traynor expects the full-year to be within the range of market expectations and significantly ahead of last year. Current market expectations for pretax profit are in the range of GBP17.0 million to GBP18.5 million. Reports insolvency numbers have returned to pre-pandemic levels due to increased liquidations.

----------

Gooch & Housego PLC - Somerset, England-based photonics company - Reports strong and improving levels of overall demand in the first four months of its financial year which ends September 30. The company reports a record order book of GBP110.5 million at January 31, up 16% from GBP95.0 million at the same time the previous year. Notes high demand for industrial lasers. Expects trading to have a slightly higher second half weighting than anticipated but says full-year outlook remains unchanged.

----------

Great Western Mining Corp PLC - London-based mineral exploration and development company with operations in the US - Says 51 mineralised spoil heaps have now been located at Mineral Jackpot in Nevada, US. Notes average grades of vein material of 1.57 grams per tonne of gold and average grades of altered wall rock of 0.04 grams per tonne of gold. Says spoil heaps were composed of average 5% vein material and 50% altered wall rock. Chair Brian Hall calls the results "highly encouraging".

----------

Union Jack Oil PLC - Bath, England-based oil and gas company with operations across the UK - Says it intends to adopt a capital allocation and distribution policy to allow the payment of a dividend or implement a share repurchase programme. This comes as a result of its current performance, principally at the Wressle development, the company explains.

----------

BiVictriX Therapeutics PLC - Cheshire, England-based biotechnology company - Expands its therapeutic pipeline with two additional programmes, BVX002 and BVX003. BVX002 and BVX003 target novel cancer-specific twin antigen fingerprints and enable the targeting of several haematological and solid tumour cancer indications. Both are entering the early stages of drug development.

----------

Okyo Pharma Ltd - London-based biopharmaceutical company focused on eye diseases and ocular pain - Receives patent from the US Patent & Trademark Office covering OK-101 to treat neuropathic pain. OK-101 is the company's anti-inflammatory drug being developed to treat dry eye disease. Adds the drug is expected to begin a phase two clinical trial in the fourth quarter of 2022.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical company - Announces updated survival data from its phase one/two study investigating the safety and efficacy of bexmarilimab. Bexmarilimab is an investigative immunotherapy with the potential to provide immune stimulation for difficult-to-treat cancers, Faron explains. Study demonstrates an estimated median progression free survival of 59 days and an estimated median overall survival of 157 days. Chief Medical Officer Marie-Louise Fjallskog says the data shows late-stage cancer patients who receive clinical benefit from bexmarilimab can "achieve long term survival".

----------

Chesterfield Resources PLC - London-based gold and copper company operating in Canada and Cyprus - Says drilling at its Troodos West project in Cyprus has significantly enhanced the prospectivity at three target areas, Orchard, Evlim and Evlim South, and has also established a 12 kilometre geological trend that the company considers key to controlling several mineralised systems. Adds that this 12 kilometre trend, named the Westline Trend, will now be the focus of its 2022 exploration campaign, due to commence shortly.

----------

Invinity Energy Systems PLC - London-based energy storage company - Wins GBP708,371 of funding from the UK Department for Business, Energy & Industrial Strategy for the Longer Duration Energy Storage Demonstration competition. The award will fund a comprehensive planning and feasibility study on what Invinity says could become one of the UK's largest co-located solar and energy storage projects. Work on the phase one feasibility study has already commenced and is expected to progress throughout 2022, the company adds.

----------

Technology Minerals PLC - London-based battery metals company - Says its wholly-owned subsidiary, Technology Minerals Cameroon Ltd, has applied for five exploration permits in Cameroon. The company says it has now received copies of all these permits and has instructed Technology Minerals Cameroon's legal counsel to verify the validity of the permits.

----------

Sanderson Design Group PLC - Buckinghamshire, England-based luxury interior furnishings company - Announces that its brand Morris & Co is launching a second collection of fabrics and wallpapers in collaboration with architect and designer Ben Pentreath. The collection will launch in March.

----------

Mirriad Advertising PLC - London-based advertising company - Signs partnership with unnamed company which it describes as "Canada's largest TV and digital media conglomerate". Says the partnership is strategically important for the North American market. Does not disclose financial details of the partnership. Mirriad adds that US campaign revenues were up by over 800% during the 2021 holiday season compared to 2020.

----------

SEEEN PLC - London-based AI-focused media platform - Forms strategic partnership with Auckland-based media intelligence platform Kinetiq Inc. The companies plan to provide "end-to-end" solutions for brands, networks and publishers to better manage and measure audience experiences, SEEEN explains.

----------

Cohort PLC - Reading, England-based - Says that its SEA subsidiary has been appointed to supply its torpedo launcher systems to South Korea-based ship building company Hyundai Heavy Industries Co Ltd. Says the multi-million pound contract will see the first Philippine Navy corvette delivered in 2023 and the second in 2025.

----------

Arena Events Group PLC - St Ives, England-based events management company - Acquisition by IHC Industiral Holding LLC and Tasheel Holding Group LLC completes. Shares in Arena were subsequently suspended.

----------

Drax Group PLC - Yorkshire, England-based power generation company - Provisionally secures agreements to provide 621 megawatts of capacity from its pumped storage and hydro assets. Drax says agreements are at the price of GBP30.59 per kilowatt for the period between October 2025 to September 2026. Expects income of GBP18 million for that period. Adds these agreements are in addition to its existing agreements.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Says that First Development Resources Ltd, a company in which Power Metal holds a 83% interest, has received notification from the Northern Territory Government Department of Industry, Tourism & Trade that all three Selta project mineral exploration licences have now been granted for a term of six years. The Selta project is located in Australia's Northern Territory and has been declared prospective for uranium mineralisation.

----------

Curzon Energy PLC - London-based energy company - Refinances and extends the outstanding loan between itself and Redcar, England-based chemical recycling company Poseidon Plastics Ltd. On February 3, a loan agreement of GBP500,000 was made available and due for repayment on February 14. Companies agree to increase the size of the loan facility by GBP245,000 and to refinance all outstanding amounts to February 14, 2023.

----------

Schroder UK Public Private Trust PLC - London-based investment company - Says its portfolio company Atom Bank has raised more than GBP75 million in new equity priced at 70 pence per share. Says this aids company as it grows its profitability and drives towards an IPO. The impact of the funding round will also be reflected in Schroder's next net asset value update, due in April.

----------

Amur Minerals Corp - Khabarovsk, Russia-based nickel copper sulphide mineral exploration company focused in Russia - Says that there is no impact on its operations or activities within Russia following a review of UK and US sanction documentation. Adds that no individual or entity identified within the documents is associated with the company in any way.

----------

Pembridge Resources PLC - London-based mining company with operations in Canada - Says Minto Metals Corp, a company it acquired in 2019, has received a new exploration permit. The 10-year class four quartz mining land use permit was granted by the Yukon Government in Canada. The permit enables Minto to diamond drilling, geophysical surveys and other associated exploration land-use activities on its mining claims, including the Minto Mine property. Adds that Minto has recently approved a CAD9.2 million - around USD7.2 million - exploration programme for 2022.

----------

Avon Protection PLC - Wiltshire, England-based respiratory protection equipment company - Reports that Non-Executive Director Bruce Thompson buys 5,000 shares at a price of GBP10.089 each. Purchase totals GBP50,445.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 Dec 2023 11:01

Faron publishes cancer immunotherapy study findings

(Sharecast News) - Faron Pharmaceuticals announced the publication of the comprehensive findings from the groundbreaking phase one and two 'MATINS' trial of bexmarilimab on Thursday - its humanised monoclonal anti-CLEVER-1 antibody aimed at transforming the landscape of anticancer immunotherapies.

Read more
6 Nov 2023 11:03

IN BRIEF: Faron Pharmaceuticals starts Phase 2 of Bexmab trial

Faron Pharmaceuticals Ltd - Finland-based clinical-stage biopharmaceutical company - Initiates Phase 2 of Bexmab study investigating humanised antibody bexmarilimab in patients with aggressive myeloid leukemias. Says it has selected hypomethylating agents-refractory or relapsed myelodysplastic syndromes (MDS) as the initial indication, based on US Food & Drug Administration guidance. Phase 1 data "demonstrated that optimal target engagement can be achieved with three milligrams per kilogram dosing" with both three and six milligram cohorts showing the "highest immune activation", while the drug produced a 50% remission rate in doublet dose cohorts.

Read more
6 Nov 2023 10:31

Faron reveals details of next stage of bexmarilimab study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that, following guidance from the US Food and Drug Administration (FDA), the initial indication for phase two advancement in the study investigating bexmarilimab in combination with standard of care, would focus on hypomethylating agents (HMAs)-refractory or relapsed myelodysplastic syndromes (MDS).

Read more
30 Oct 2023 15:56

TRADING UPDATES: Bezant optimistic after Hope & Gorob estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
11 Oct 2023 14:53

Faron Pharmaceuticals upbeat on latest data in blood cancer trials

(Sharecast News) - Faron Pharmaceuticals announced encouraging updated data from its ongoing phase one and two 'BEXMAB' study into relapsed or refractory (r/r) acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) treatments on Wednesday.

Read more
11 Oct 2023 14:01

IN BRIEF: Faron Pharmaceuticals' Bexmarilimab shows 50% remission rate

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Says Bexmarilimab study shows 50% remission rate for patients with in relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. Says eight of eleven patients were complete responders or complete responders with incomplete blood recovery. Adds Bexmarilimab continues to be well-tolerated at all tested dose levels, as no dose-limiting toxicity has been observed.

Read more
21 Sep 2023 14:45

Faron Pharmaceuticals names interim chief medical officer

(Sharecast News) - Cancer immunotherapy-focussed biopharmaceutical firm Faron Pharmaceuticals named Dr Birge Berns as its interim chief medical officer on Thursday, with the transition becoming effective on 22 September, with Dr Berns operating from the UK.

Read more
21 Sep 2023 12:12

TRADING UPDATES: Faron appoints Birge Berns as interim medical officer

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Sep 2023 15:46

UK shareholder meetings calendar - next 7 days

Monday 18 September 
Baillie Gifford US Growth Trust PLCAGM
Inteliqo LtdAGM
LendInvest PLCAGM
Rosslyn Data Technologies PLCGM re fundraise
Tuesday 19 September 
Africa Opportunity Fund LtdAGM
Aston Martin Lagonda Global Holdings PLCGM re supply arrangement with Lucid Group Inc
Augmentum Fintech PLCAGM
Beacon Rise Holdings PLCAGM
Begbies Traynor Group PLCAGM
Chill Brands Group PLCAGM
DP Aircraft I LtdAGM
Great Southern Copper PLCAGM
Manolete Partners PLCAGM
Moonpig Group PLCAGM
Oxford Instruments PLCAGM
ProCook Group PLCAGM
SRT Marine Systems PLCAGM
Unicorn Mineral Resources PLCAGM
Wednesday 20 September 
Accsys Technologies PLCAGM
Frasers Group PLCAGM
Games Workshop Group PLCAGM
Hidong Estate PLCAGM
IG Group Holdings PLCAGM
Ilika PLCAGM
Nippon Active Value Fund PLCGM re assets rollover
Quiz PLCAGM
Seed Innovations LtdAGM
STS Global Income & Growth Trust PLCAGM
Thursday 21 September 
Ascent Resources PLCGM re audited annual accounts
Intercede Group PLCAGM
Kore Potash PLCGM re capital raise
Liontrust Asset Management PLCAGM
Mercia Asset Management PLCAGM
Molecular Energies PLCAGM
Oberon Investments Group PLCAGM
Pelatro PLCGM re AIM cancellation
Sosandar PLCAGM
Thruvision Group PLCAGM
Trakm8 Holdings PLCAGM
Van Elle Holdings PLCAGM
Friday 22 September 
Argos Resources LtdGM re members voluntary liquidation
B&M European Value Retail SAGM re appointing Lasry as director
Faron Pharmaceuticals LtdEGM re election of new board members
Stranger Holdings PLCAGM
SysGroup PLCAGM
TI Fluid Systems PLCGM re waiver resolution
Odyssean Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
5 Sep 2023 14:22

Evgen Pharma hires interim CFO from Faron, chair to retire this month

(Alliance News) - Evgen Pharma on Tuesday said Non-Executive Chair Barry Clare will retire at its next board meeting, and announced the hiring of interim Chief Financial Officer Toni Hanninen.

Read more
29 Aug 2023 10:23

AIM WINNERS & LOSERS: Pelatro plummets on delisting plans

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
29 Aug 2023 10:15

Faron shares surge on FDA drug designation; loss widens on costs

(Alliance News) - Faron Pharmaceuticals Ltd on Tuesday said its interim loss widened on higher costs but saw shares soar after it gained a US Food & Drug Administration orphan drug designation for Bexmarilimab.

Read more
22 Aug 2023 15:46

UK earnings, trading statements calendar - next 7 days

Wednesday 23 August 
Angling Direct PLCTrading Statement
Costain Group PLCHalf Year Results
Thursday 24 August 
Benchmark Holdings PLCQ3 Results
CRH PLCHalf Year Results
Harbour Energy PLCHalf Year Results
Hays PLCFull Year Results
Hunting PLCHalf Year Results
James Cropper PLCHalf Year Results
Macfarlane Group PLCHalf Year Results
Princess Private Equity Holding LtdHalf Year Results
Redcentric PLCFull Year Results
South32 LtdFull Year Results
Tribal Group PLCHalf Year Results
Friday 25 August 
no events scheduled 
Monday 28 August 
no events scheduled 
Tuesday 29 August 
Amaroq Minerals LtdHalf Year Results
Bunzl PLCHalf Year Results
Dalata Hotel Group PLCHalf Year Results
Faron Pharmaceuticals LtdHalf Year Results
PureTech Health PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jul 2023 10:27

Faron Pharmaceuticals sees positive data from phase 1 BEXMAB trial

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said data from its phase 1 BEXMAB study has shown positive data.

Read more
29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.